Ex-FDA chief warns of economic impact of coronavirus
Former FDA Commissioner Dr. Scott Gottlieb says the scope of the epidemic will likely change over the next two weeks.
Watch CBS News
Former FDA Commissioner Dr. Scott Gottlieb says the scope of the epidemic will likely change over the next two weeks.
The former FDA chief weighs in on the toll the pandemic is taking on U.S. hospitals.
President Trump announced that a drug commonly used to treat malaria could possibly be used to treat coronavirus symptoms, after it goes through clinical trials. However, officials maintained that currently, there is no drug on the market that is FDA-approved to treat coronavirus. Meanwhile in Congress, Senate Majority Leader Mitch McConnell unveiled a financial aid package to help small businesses and industries deeply affected by the coronavirus, like airlines. The proposal has gotten criticism from Democrats, who say it does more to help corporations than workers. Weijia Jiang breaks down what else Washington, D.C. is doing to try and contain the coronavirus' spread.
President Trump expressed optimism on Thursday when he announced that a drug commonly used to treat malaria has been FDA-approved to ease symptoms of the coronavirus. Dr. David Agus joins "CBS This Morning" to discuss this and other options currently being tried and tested to help battle the illness.
The former FDA chief says hospitals are at risk of being overwhelmed during the crisis.
The former FDA commissioner says "mitigation is clearly working" but surveillance measures will be needed to contain future outbreaks.
The former FDA chief says a report is needed on "what China did or didn't tell the world" about coronavirus.
Millions of Americans have lost their jobs or been furloughed due to the coronavirus pandemic, but reopening the economy too soon could make things even worse. Former FDA Commissioner Dr. Scott Gottlieb joins "CBS Evening News" with more on what it will take to get America back to work.
Dr. Scott Gottlieb, the former director of the FDA, says states are currently "largely on their own" to obtain supplies needed for widespread coronavirus testing.
Scott Gottlieb told 'Face the Nation" that the state is "certainly not out of the woods" when it comes to coronavirus recovery
An experimental drug is showing promise in treating the coronavirus. Preliminary results from a clinical trial carried out by the National Institutes of Health found patients taking remdesivir recovered an average of four days sooner than those on a placebo. The FDA may now consider an emergency approval to allow for broad use of the drug, though the findings still need to be peer-reviewed. Dr. Tara Narula spoke to a patient in that study, and a scientist fighting to get more answers.
Protests erupted in Chicago over stay-at-home orders. Similar frustration is boiling over in Charlotte, North Carolina. Janet Shamlian reports.
As the FDA orders all companies that sell antibody tests for the coronavirus to submit data proving their tests are accurate, one of them from Roche could prove to be highly accurate. Chief medical correspondent Dr. Jon LaPook reports.
The former FDA commissioner said a new rapid antigen test that can be administered in doctors' offices could be key in stopping the spread.
Production is ramping up on a new antigen test that could quickly determine if someone has been infected by the coronavirus. President Trump said production could double from 150,000 to 300,000 tests within weeks. Dr. Jon LaPook has a look.
Four of the Trump administration's top medical experts testified about the U.S. response to the coronavirus before the Senate HELP committee Tuesday. CBS News political correspondent Ed O'Keefe and Reuters White House correspondent Jeff Mason join CBSN's Elaine Quijano to recap the hearing.
More than 100 potential coronavirus vaccines are being tested at record speeds. As pressure builds to get a vaccine approved, some experts say there could be considerable safety concerns in speeding up the process. Carolyn Johnson, a science reporter for The Washington Post, joins CBSN's Elaine Quijano to discuss the latest on vaccine development.
The former FDA commissioner said a new rapid antigen test that can be administered in doctors' offices could be key in stopping the spread.
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired Sunday, May 10, 2020, on "Face the Nation."
Antigen tests can diagnose active infections by detecting the earliest toxic traces of the virus rather than genetic code of the virus itself.
The FDA says he tested negative for COVID-19.
Having the coronavirus antibodies is only one piece of the puzzle.
Swiss biotech firm says its blood test is 100% accurate in detecting the presence of coronavirus antibodies.
While the New York tri-state region is experiencing a drop in coronavirus cases and hospitalizations, Gottlieb said the number of cases is rising daily in about 20 other states.
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired Sunday, May 3, 2020, on "Face the Nation."